Background Image
Table of Contents Table of Contents
Previous Page  288 / 337 Next Page
Information
Show Menu
Previous Page 288 / 337 Next Page
Page Background

SCIENTIFIC PROGRAMME

288

WEDNESDAY

THURSDAY

FRIDAY

SATURDAY

S-104

Symposium

17.15– 18.45 h

|

Room Weimar 3

TOPIC 3:

Psychotic disorders, F2

The role of oligodendrocytes in symp-

tom dimensions of schizophrenia

Chairs:

Johann Steiner, Magdeburg

(Germany)

Andrea Schmitt, Munich (Germany)

001

The impact of white matter micro-

structure on clinical symptoms: insights

from DTI studies

Berend Malchow, Munich (Germany)

002

Clinical heterogeneity in schizophre-

nia is associated with the heterogeneity

of oligodendrocyte abnormalities

Natalya Uranova, Moscow (Russia)

003

Oligodendrocyte number in brain

regions of schizophrenia patients and

association with cognitive deficits

Andrea Schmitt, Munich (Germany)

Berend Malchow, Hans-Gert Bernstein,

Johann Steiner, Christoph Schmitz, Bernhard

Bogerts, Verena Nowastowski, Katharina

Wetzestein, Peter Falkai

004

Increased nuclear Olig1-expression:

a regenerative attempt to compensate

oligodendrocyte loss?

Johann Steiner, Magdeburg (Germany)

Jennifer Mosebach, Gerburg Keilhoff,

Kolja Schiltz, Hans-Gert Bernstein,

Bernhard Bogerts

S-105

Symposium

17.15– 18.45 h

|

Room M5

TOPIC 23:

Health care research and models

Person-centered psychiatry and medicine

– concept and application

Chairs:

Wolfgang Gaebel, Dusseldorf

(Germany)

Juan E. Mezzich, New York (USA)

001

Conceptual bases and international

development of person-centered psychia-

try and medicine

Juan E. Mezzich, New York (USA)

002

European perspectives on per-

son-centered psychiatry

Wolfgang Gaebel, Dusseldorf (Germany)

003

The International College of person

centered medicine and its life course

projections

James Appleyard, London (United Kingdom)

004

The World Medical Association and

person centered medicine

Otmar Kloiber, Ferney-Voltaire (France)